Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06080659 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity

Study acronym: NODAL
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site contact updatedv4
  2. Site contact updatedv3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 2023 to Nov 6, 2023
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the NODAL clinical trial is to demonstrate the feasibility of new, low-cost, non-invasive biomarkers of neurodegenerative pathologies as early Alzheimer and Parkinson, based on the estimation of the multimodal connectome.
Trial Details
NCT Number NCT06080659
Lead Sponsor Rennes University Hospital
Conditions
(from sponsor)		 Alzheimer Disease, Early Onset, Parkinson Disease
Related terms Alzheimer Disease, Parkinson Disease
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov